A decade of oncology drug development: FDA-approved drug trends between 2005 and 2015

被引：0
|
作者：
Asabere, Akwasi [1 ]
Bastian, Alex [1 ]
机构：
[1] GfK Market Access, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e17788
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17788
引用
收藏
页数：1
相关论文
共 50 条
  • [1] FDA-approved drug promotes remyelination
    Sarah Lempriere
    Nature Reviews Neurology, 2022, 18 : 637 - 637
  • [2] FDA-approved drug promotes remyelination
    不详
    NATURE REVIEWS NEUROLOGY, 2022, 18 (11) : 637 - 637
  • [3] Reporting of Drug Benefit in FDA-Approved Prescription Drug Labeling
    Desai, Bansri
    Hong, Kyungwan
    Powers, John H.
    Doshi, Peter
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (01) : 377 - 379
  • [4] Reporting of Drug Benefit in FDA-Approved Prescription Drug Labeling
    Bansri Desai
    Kyungwan Hong
    John H. Powers
    Peter Doshi
    Journal of General Internal Medicine, 2020, 35 : 377 - 379
  • [5] Genomic biomarkers in FDA-approved drug labels
    Mummaneni, Padmaja
    Amur, Shashi G.
    Goodsaid, Federico
    Rudman, Allen
    Frueh, Felix W.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1088 - 1088
  • [6] Deuterated Drug Molecules: Focus on FDA-Approved Deutetrabenazine
    DeWitt, Sheila H.
    Maryanoff, Bruce E.
    BIOCHEMISTRY, 2018, 57 (05) : 472 - 473
  • [7] Miltefosine, an FDA-approved drug for the 'orphan disease', leishmaniasis
    Berman, Jonathan
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (06): : 727 - 735
  • [8] The FDA-Approved Drug Apremilast Suppresses Alcohol Intake
    Ozburn, Angela
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 38 - 38
  • [9] Novel FDA-approved zavegepant drug for treating migraine
    Ahmed, Usaid
    Saleem, Muhammad Meeran
    Osman, Mohamed Ashraf
    Shamat, Shamat Fathi
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (02): : 923 - 925
  • [10] Ocular toxicities of FDA-approved antibody drug conjugates
    Vetsa, Shaurey
    Zhang, Stephanie
    Kay, Walker
    Kelkar, Neil
    Ghosh, Arko
    Alam, Suhail
    Hoopes, Phillip C.
    Moshirfar, Majid
    CUTANEOUS AND OCULAR TOXICOLOGY, 2024, 43 (04) : 316 - 327
12345